Few consumers rely on Web sites created by pharmaceutical companies for drug treatment information.
Few consumers rely on Web sites created by pharmaceutical companies for drug treatment information. That's the conclusion of a poll of 800 consumers conducted by market research firm Prospectiv. The on-line survey also found that consumers opt for general health Web sites (54%) and ailment-specific sites (37%) over pharmaceutical company portals (4%). In addition, when asked what would pique their interest in specific drug treatments for their conditions, more than half (55%) identified drug samples, followed by e-newsletters (35%) and coupons (10%) as their top incentives.